The changes of antifungal susceptibilities caused by the phenotypic switching of Candida species in 229 patients with vulvovaginal candidiasis
- PMID: 30101450
- PMCID: PMC6430360
- DOI: 10.1002/jcla.22644
The changes of antifungal susceptibilities caused by the phenotypic switching of Candida species in 229 patients with vulvovaginal candidiasis
Abstract
Objective: This study was to investigate the changes of antifungal susceptibilities caused by the phenotypic switching in patients with vulvovaginal candidiasis (VVC).
Methods: 229 women were enrolled in this study. The vaginal smears of these patients were collected and gram stained for fungal microscopic observation. The vaginal discharge of them in cotton swabs was cultured in sabouraud's agar with chloramphenicol medium. After fungal culture, fungal identification was analyzed using CHROM agar Candida chromogenic and identification medium. Then, the in vitro antifungal susceptibility testing was carried out using the standardized CLSI M27-A2 broth microdilution method.
Results: 64.63% of Candia species in patients with VVC were Candida albicans and the remainders were non-albicans Candida species. The phenotypic switching was observed in 91.22% of C. albicans infection. In antifungal susceptibility testing, the susceptible rates of C. albicans to voriconazole, fluconazole and itraconazole were significantly higher than that of non-albicans Candida species (P = 0.00, 0.00, 0.00). No matters in patients infected with C. albicans or with non-albicans Candida species, the susceptible rate to fluconazole of the clinical isolates with phenotypic switching was significantly higher than that without phenotypic switching (P = 0.01, 0.01).
Conclusions: In the study, C. albicans was the commonest pathogenic species in patients with VVC, in which the phenotypic switching was easy to occur. The susceptible rates of C. albicans to all antifungal drugs were higher than that of non-albicans Candida species. The susceptible rate to fluconazole was all influenced by the phenotypic switching in C. albicans and non-albicans Candida species.
Keywords: Candida albicans; non-albicans Candida; antifungal susceptibility testing; phenotypic switching; susceptible rate.
© 2018 Wiley Periodicals, Inc.
Figures



Similar articles
-
Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.BMC Pregnancy Childbirth. 2020 May 6;20(1):266. doi: 10.1186/s12884-020-02963-3. BMC Pregnancy Childbirth. 2020. PMID: 32375724 Free PMC article.
-
Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.BMC Infect Dis. 2021 Jun 3;21(1):523. doi: 10.1186/s12879-021-06192-7. BMC Infect Dis. 2021. PMID: 34082699 Free PMC article.
-
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.BMC Womens Health. 2018 Jun 15;18(1):94. doi: 10.1186/s12905-018-0607-z. BMC Womens Health. 2018. PMID: 29902998 Free PMC article.
-
Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression.Med Mycol. 2022 Jul 9;60(7):myac037. doi: 10.1093/mmy/myac037. Med Mycol. 2022. PMID: 35781514
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
Cited by
-
Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis.Front Microbiol. 2020 Nov 11;11:544480. doi: 10.3389/fmicb.2020.544480. eCollection 2020. Front Microbiol. 2020. PMID: 33262741 Free PMC article. Review.
-
Virulence Factors of Candida spp. and Host Immune Response Important in the Pathogenesis of Vulvovaginal Candidiasis.Int J Mol Sci. 2022 May 24;23(11):5895. doi: 10.3390/ijms23115895. Int J Mol Sci. 2022. PMID: 35682581 Free PMC article. Review.
-
Vaginal mycobiome characteristics and therapeutic strategies in vulvovaginal candidiasis (VVC): differentiating pathogenic species and microecological features for stratified treatment.Clin Microbiol Rev. 2025 Jun 12;38(2):e0028424. doi: 10.1128/cmr.00284-24. Epub 2025 Apr 22. Clin Microbiol Rev. 2025. PMID: 40261031 Review.
-
Resistance to Fluconazole of Candida albicans in Vaginal Isolates: a 10-Year Study in a Clinical Referral Center.Antimicrob Agents Chemother. 2023 May 17;67(5):e0018123. doi: 10.1128/aac.00181-23. Epub 2023 Apr 24. Antimicrob Agents Chemother. 2023. PMID: 37093005 Free PMC article.
-
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.Front Immunol. 2022 Jul 28;13:959740. doi: 10.3389/fimmu.2022.959740. eCollection 2022. Front Immunol. 2022. PMID: 35967437 Free PMC article.
References
-
- Amouri I, Sellami H, Borji N, et al. Epidemiological survey of vulvovaginal candidosis in Sfax, Tunisia. Mycoses 2011;54:e499Y505. - PubMed
-
- Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369:1961‐1971. - PubMed
-
- Fidel PL Jr. History and update on host defense against vaginal candidiasis. Am J Reprod Immunol. 2007;57:2‐12. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources